Detalhe da pesquisa
1.
Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens.
Oncologist
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630540
2.
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Cancer
; 124(18): 3677-3683, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30307610
3.
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial.
Lancet Oncol
; 16(6): 729-36, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981813
4.
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study.
Lancet Oncol
; 16(3): 293-300, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25681967
5.
High-dose chemotherapy with autologous stem-cell transplantation for relapsed metastatic germ cell tumors The Alberta experience.
Can Urol Assoc J
; 18(3): E73-E79, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010229
6.
Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
BMC Cancer
; 13: 133, 2013 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23514246
7.
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma.
Eur Urol
; 84(1): 109-116, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707357
8.
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol Oncol
; 2023 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914579
9.
Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma.
JAMA Netw Open
; 5(6): e2216379, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687336
10.
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis.
J Geriatr Oncol
; 12(5): 820-826, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33674246
11.
Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma.
Eur Urol
; 78(4): 615-623, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32362493
12.
Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol Oncol
; 2(6): 643-648, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31411994
13.
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial.
Eur J Cancer
; 108: 69-77, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30648632
14.
Corrigendum to "Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma" [Eur Urol 2023].
Eur Urol
; 83(6): e166-e167, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967358
15.
Assessment of quality of life using Skindex-16 in patients with advanced basal cell carcinoma treated with vismodegib in the STEVIE study.
Eur J Dermatol
; 28(6): 775-783, 2018 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30698147
16.
Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas.
Clin Cancer Res
; 24(18): 4399-4406, 2018 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848572
17.
Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category.
Eur Urol
; 71(6): 970-978, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27771126
18.
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Eur Urol
; 71(2): 204-209, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27318422
19.
Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group.
BMC Cancer
; 6: 112, 2006 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-16670021
20.
Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy.
Urol Oncol
; 24(6): 472-86, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17138127